Somatropin

Generic Name: somatropin

Over-the-Counter (OTC)

Brand Names:

Zomacton

11 DESCRIPTION Somatropin is a human growth hormone (GH) produced by recombinant DNA technology using Escherichia coli. The protein is comprised of 191 amino acid residues and has a molecular weight of about 22,124 daltons. The amino acid sequence is identical to that of human growth hormone of pituitary origin. ZOMACTON (somatropin) for injection is a sterile, white lyophilized powder, intended for subcutaneous injection after reconstitution with the accompanying diluent.

Overview

11 DESCRIPTION Somatropin is a human growth hormone (GH) produced by recombinant DNA technology using Escherichia coli. The protein is comprised of 191 amino acid residues and has a molecular weight of about 22,124 daltons. The amino acid sequence is identical to that of human growth hormone of pituitary origin. ZOMACTON (somatropin) for injection is a sterile, white lyophilized powder, intended for subcutaneous injection after reconstitution with the accompanying diluent.

Uses

1 INDICATIONS AND USAGE ZOMACTON is a recombinant human growth hormone indicated for: Pediatric: Treatment of pediatric patients with growth failure due to inadequate secretion of endogenous growth hormone (GH), short stature associated with Turner syndrome, idiopathic short stature (ISS), short stature or growth failure in short stature homeobox-containing gene (SHOX) deficiency, and short stature born small for gestational age (SGA) with no catch-up growth by 2 years to 4 years.

Dosage

2 DOSAGE AND ADMINISTRATION Administer by subcutaneous injection to the back of upper arm, abdomen, buttock, or thigh with regular rotation of injection sites ( 2.1 ) Pediatric dosage: Divide the calculated weekly dosage into equal doses given either 3, 6, or 7 days per week ( 2.2 ) GH deficiency : 0.18 mg/kg/week to 0.3 mg/kg/week ( 2.2 ) Turner syndrome: Up to 0.375 mg/kg/week ( 2.2 ) ISS : Up to 0.37 mg/kg/week ( 2.2 ) SHOX deficiency: 0.35 mg/kg/week ( 2.2 ) SGA: Up to 0.47 mg/kg/week ( 2.2 ) Adult dosage: Either of the following two dosing regimens may be used: Non-weight based dosing : Initiate with a dose of approximately 0.2 mg/day (range, 0.15 mg/day to 0.3 mg/day) and increase the dose every 1 to 2 months by increments of approximately 0.1 mg/day to 0.2 mg/day, according to indiv...

Side Effects

6 ADVERSE REACTIONS The following important adverse reactions are also described elsewhere in the labeling: Increased mortality in patients with acute critical illness [see Warnings and Precautions (5.1) ] Fatalities in pediatric patients with Prader-Willi syndrome [see Warnings and Precautions (5.2) ] Neoplasms [see Warnings and Precautions (5.3) ] Glucose intolerance and diabetes mellitus [see Warnings and Precautions (5.4) ] Intracranial hypertension [see Warnings and Precautions (5.5) ] Severe hypersensitivity [see Warnings and Precautions (5.6) ] Fluid retention [see Warnings and Precautions (5.7) ] Hypoadrenalism [see Warnings and Precautions (5.8) ] Hypothyroidism [see Warnings and Precautions (5.9) ] Slipped capital femoral epiphysis in pediatric patients [see Warnings and Precauti...

Interactions

7 DRUG INTERACTIONS Table 7 includes a list of drugs with clinically important drug interactions when administered concomitantly with ZOMACTON and instructions for preventing or managing them. Table 7: Clinically Important Drug Interactions with ZOMACTON Glucocorticoids Clinical Impact: Microsomal enzyme 11β-hydroxysteroid dehydrogenase type 1 (11βHSD-1) is required for conversion of cortisone to its active metabolite, cortisol, in hepatic and adipose tissue. ZOMACTON inhibits 11βHSD-1. Consequently, individuals with untreated GH deficiency have relative increases in 11βHSD-1 and serum cortisol. Initiation of ZOMACTON may result in inhibition of 11βHSD-1 and reduced serum cortisol concentrations.

Warnings

5 WARNINGS AND PRECAUTIONS Increased Risk of Neoplasm: Second neoplasms have occurred in childhood cancer survivors. Monitor patients with preexisting tumors for progression or recurrence. ( 5.3 ) Glucose Intolerance and Diabetes Mellitus: ZOMACTON may decrease insulin sensitivity, particularly at higher doses. Monitor glucose levels periodically in all patients receiving ZOMACTON, especially in patients with existing diabetes mellitus or at risk for development. ( 5.4 ) Intracranial Hypertension (IH): Has been reported usually within 8 weeks of initiation. Perform fundoscopic examinations prior to initiation and periodically thereafter. If papilledema occurs, stop treatment. ( 5.5 ) Hypersensitivity: Serious hypersensitivity reactions may occur. 4 CONTRAINDICATIONS ZOMACTON is contraindicated in patients with: Acute critical illness after open heart surgery, abdominal surgery or multiple accidental trauma, or those with acute respiratory failure due to the risk of increased mortality with use of pharmacologic doses of somatropin [see Warnings and Precautions (5.1) ] .

Pregnancy

8.1 Pregnancy Risk Summary The ZOMACTON 5 mg diluent contains benzyl alcohol. Because benzyl alcohol is rapidly metabolized by a pregnant woman, benzyl alcohol exposure in the fetus is unlikely. However, adverse reactions have occurred in premature neonates and low birth weight infants who received intravenously administered benzyl alcohol-containing drugs [see Warnings and Precautions (5.13) and Use in Specific Populations (8.4) ].

Storage

16.2 Storage and Handling Before Reconstitution Store ZOMACTON vials refrigerated at 36° to 46°F (2° to 8°C) in the original carton to protect from light. Avoid freezing the accompanying diluent.

Frequently Asked Questions

What is Somatropin used for?

1 INDICATIONS AND USAGE ZOMACTON is a recombinant human growth hormone indicated for: Pediatric: Treatment of pediatric patients with growth failure due to inadequate secretion of endogenous growth hormone (GH), short stature associated with Turner syndrome, idiopathic short stature (ISS), short stature or growth failure in short stature homeobox-containing gene (SHOX) deficiency, and short stature born small for gestational age (SGA) with no catch-up growth by 2 years to 4 years.

What are the side effects of Somatropin?

6 ADVERSE REACTIONS The following important adverse reactions are also described elsewhere in the labeling: Increased mortality in patients with acute critical illness [see Warnings and Precautions (5.1) ] Fatalities in pediatric patients with Prader-Willi syndrome [see Warnings and Precautions (5.2) ] Neoplasms [see Warnings and Precautions (5.3) ] Glucose intolerance and diabetes mellitus [see Warnings and Precautions (5.4) ] Intracranial hypertension [see Warnings and Precautions (5.5) ] Severe hypersensitivity [see Warnings and Precautions (5.6) ] Fluid retention [see Warnings and Precautions (5.7) ] Hypoadrenalism [see Warnings and Precautions (5.8) ] Hypothyroidism [see Warnings and Precautions (5.9) ] Slipped capital femoral epiphysis in pediatric patients [see Warnings and Precauti...

Can I take Somatropin during pregnancy?

8.1 Pregnancy Risk Summary The ZOMACTON 5 mg diluent contains benzyl alcohol. Because benzyl alcohol is rapidly metabolized by a pregnant woman, benzyl alcohol exposure in the fetus is unlikely. However, adverse reactions have occurred in premature neonates and low birth weight infants who received intravenously administered benzyl alcohol-containing drugs [see Warnings and Precautions (5.13) and Use in Specific Populations (8.4) ].

What are the important warnings for Somatropin?

5 WARNINGS AND PRECAUTIONS Increased Risk of Neoplasm: Second neoplasms have occurred in childhood cancer survivors. Monitor patients with preexisting tumors for progression or recurrence. ( 5.3 ) Glucose Intolerance and Diabetes Mellitus: ZOMACTON may decrease insulin sensitivity, particularly at higher doses. Monitor glucose levels periodically in all patients receiving ZOMACTON, especially in patients with existing diabetes mellitus or at risk for development. ( 5.4 ) Intracranial Hypertension (IH): Has been reported usually within 8 weeks of initiation. Perform fundoscopic examinations prior to initiation and periodically thereafter. If papilledema occurs, stop treatment. ( 5.5 ) Hypersensitivity: Serious hypersensitivity reactions may occur. 4 CONTRAINDICATIONS ZOMACTON is contraindicated in patients with: Acute critical illness after open heart surgery, abdominal surgery or multiple accidental trauma, or those with acute respiratory failure due to the risk of increased mortality with use of pharmacologic doses of somatropin [see Warnings and Precautions (5.1) ] .

Related Medications

Allium Cepa, Hyssopus Officinalis, Avena Sativa, Paloondo, Urtica Dioica, Trifolium Pratense, Zingiber Officinale, Capsicum Annuum, Hepar (bovine), Hypophysis Suis, Juglans Regia, Medulla Ossis Suis, Remex Crispus, Spleen (bovine), Camphora, Magnesia Phosphorica, Ferrum Phosphoricum, Pyrogenium

allium cepa, hyssopus officinalis, avena sativa, paloondo, urtica dioica, trifolium pratense, zingiber officinale, capsicum annuum, hepar (bovine), hypophysis suis, juglans regia, medulla ossis suis, remex crispus, spleen (bovine), camphora, magnesia phosphorica, ferrum phosphoricum, pyrogenium

Non-Standardized Plant Allergenic Extract [EPC]

PURPOSE: Allium Cepa – Antioxidant Providing Blood Support,† Avena Sativa – Cellular Detoxifier and Blood Support,† Camphora – Heart and Blood Support,† Capsicum Annuum – Fatigue and Blood Support,† Ferrum Phosphoricum – Bruises, Contusions, Injuries, Sprains, Fatigue, and Blood Support,† Hepar - Liver Support,† Hypophysis Suis – Pituitary and Blood Support,† Hyssopus Officinalis – Antioxidant Providing Liver and Blood Support,† Juglans Regia – Spleen and Blood Support,† Magnesia Phosphorica – B

Carboneum Sulphuratum

carboneum sulphuratum

Uses Temporarily relieves occasional buzzing and ringing sensation in the ears, nerve discomfort, and discomfort and swelling in limbs.* *CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE. NOT FDA EVALUATED. This product is not intended to diagnose, treat, cure, or prevent any disease.

Argentum Nitricum, Natrum Muriaticum, Sulphur, Aconitum Napellus, Arsenicum Album, Rhus Tox, Adenosinum Cyclophosphoricum, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Lung (suis), Mucosa Nasalis Suis, Pantothenic Acid, Sarcolacticum Acidum, Acetylcholine Chloride, Coumarinum, Malvin, Dysentery Bacillus, Proteus (morgani)

argentum nitricum, natrum muriaticum, sulphur, aconitum napellus, arsenicum album, rhus tox, adenosinum cyclophosphoricum, funiculus umbilicalis suis, glandula suprarenalis suis, lung (suis), mucosa nasalis suis, pantothenic acid, sarcolacticum acidum, acetylcholine chloride, coumarinum, malvin, dysentery bacillus, proteus (morgani)

PURPOSE: Acetylcholine Chloride – Lung Support, Aconitum Napellus – Minor Breathing Issues, Adenosinum Cyclophosphoricum – Lung Support, Argentum Nitricum – Minor Breathing Issues, Arsenicum Album – Minor Breathing Issues, Coumarinum – Lung Support, Dysentery Bacillus – Minor Breathing Issues, Funiculus Umbilicalis Suis – Minor Breathing Issues, Glandula Suprarenalis Suis – Lung Support, Lung (Suis) – Minor Breathing Issues, Malvin – Lung Support, Mucosa Nasalis Suis – Lung Support, Natrum Muria

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.